Status:
COMPLETED
Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors
Lead Sponsor:
University of Lausanne
Collaborating Sponsors:
Pierre Fabre Laboratories
Conditions:
Fatigue
Iron Deficiency
Eligibility:
FEMALE
18-50 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine the subjective response of iron substitution (Tardyferon®) on fatigue in women blood donors with a mean serum ferritin \< 30ng/ml and to assess variation of f...
Detailed Description
* Actually, there's no recommendation to check ferritin level in blood donors, even if several studies pointed out the high prevalence of iron deficiency after a blood donation. Furthermore, some clin...
Eligibility Criteria
Inclusion
- women
- aged 18 - 50
- eligible for a blood donation
Exclusion
- men
- age below 18 or above 50
- not eligible for a blood donation (according to the blood donation eligibility guidelines of the Swiss Red Cross)
- hemochromatosis, psychiatric / thyroid / hepatic / rheumatismal / kidney or cardiopulmonary diseases that can cause fatigue
- intestinal disease or medical treatment that can perturb iron absorption and/or excretion
- donors with mental disorder or psychiatric disease that are unable to give consent
- acute or chronic inflammation
- diabetes and pregnancy
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT00689793
Start Date
November 1 2008
End Date
April 1 2011
Last Update
February 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ambulatory Care and Community Medicine, University Hospitals of Lausanne
Lausanne, Bugnon 44, Switzerland, 1011